We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

163 hedge funds and large institutions have $1.86B invested in Nektar Therapeutics in 2014 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

111% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 19

39% more call options, than puts

Call options by funds: $4.03M | Put options by funds: $2.89M

30% more capital invested

Capital invested by funds: $1.43B → $1.86B (+$432M)

12% more funds holding

Funds holding: 145 → 163 (+18)

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

Holders
163
Holders Change
+18
Holders Change %
+12.41%
% of All Funds
4.35%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
40
Increased
49
Reduced
50
Closed
19
Calls
$4.03M
Puts
$2.89M
Net Calls
+$1.14M
Net Calls Change
-$6.97M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$32.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.8M
3
PC
PointState Capital
New York
+$14.2M
4
DFO
Duquesne Family Office
New York
+$9.33M
5
Norges Bank
Norges Bank
Norway
+$7.35M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$22M
2
First Trust Advisors
First Trust Advisors
Illinois
-$16M
3
Franklin Resources
Franklin Resources
California
-$15.7M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$12.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
51
Teachers Advisors
New York
$4.19M +$4.49K +21 +0.1%
NI
52
Numeric Investors
Massachusetts
$3.95M -$3.93M -18,365 -52%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$3.7M +$168K +788 +5%
RPAM
54
Rhenman & Partners Asset Management
Sweden
$3.69M -$3.85M -18,000 -53%
OPPM
55
Opus Point Partners Management
New York
$3.68M +$3.38M +15,807 New
Asset Management One
56
Asset Management One
Japan
$3.43M +$361K +1,689 +13%
HCM
57
Harvey Capital Management
Florida
$3.42M -$19.9K -93 -0.6%
Axa
58
Axa
France
$2.67M -$2.51M -11,750 -51%
MC
59
Menta Capital
California
$2.5M +$2.3M +10,747 New
PFC
60
Phocas Financial Corp
California
$2.43M +$2.24M +10,462 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$2.39M +$8.34K +39 +0.4%
Wellington Management Group
62
Wellington Management Group
Massachusetts
$2.35M -$32.3K -151 -1%
FC
63
FIC Capital
New York
$2.28M -$1.07K -5 -0.1%
Swiss National Bank
64
Swiss National Bank
Switzerland
$2.15M +$48.5K +227 +3%
PI
65
Putnam Investments
Massachusetts
$2.11M -$10.5K -49 -0.5%
NFA
66
Nationwide Fund Advisors
Ohio
$1.83M +$16.7K +78 +1%
RFC
67
Russell Frank Company
Washington
$1.83M +$781K +3,652 +85%
FSA
68
Franklin Street Advisors
North Carolina
$1.77M – – –
ProShare Advisors
69
ProShare Advisors
Maryland
$1.74M -$52.6K -246 -3%
AQR Capital Management
70
AQR Capital Management
Connecticut
$1.69M +$293K +1,371 +23%
HPCM
71
High Pointe Capital Management
Illinois
$1.67M -$186K -871 -11%
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$1.65M – – –
State of New Jersey Common Pension Fund D
73
State of New Jersey Common Pension Fund D
New Jersey
$1.63M – – –
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$1.53M +$13K +61 +0.9%
Barclays
75
Barclays
United Kingdom
$1.46M +$1.01M +4,744 +271%
1 2
3
4 5

NKTR Hedge Fund Activity: Q4 2014 in Review

163 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q4 2014, worth a combined $1.86B — up 30% from $1.43B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NKTR positions and 19 closed out — a net gain of 21 holders — while 49 added to existing stakes and 50 trimmed.

The largest buyer was Invesco, adding an estimated $32.7M. The largest seller was NEA Management Company, exiting entirely with an estimated $22M sold.

  • 163 institutional investors held Nektar Therapeutics (NKTR) as of Q4 2014, up from 145 in Q3 2014.
  • Funds reported $1.86B of Nektar Therapeutics stock for Q4 2014, up 30% quarter-over-quarter.
  • 40 funds opened new Nektar Therapeutics positions in Q4 2014 and 19 closed out, a net change of +21 holders.
  • The largest Nektar Therapeutics buyer in Q4 2014 was Invesco, an estimated $32.7M added.
  • The largest Nektar Therapeutics seller in Q4 2014 was NEA Management Company, an estimated $22M sold.

Based on aggregated 13F filings for Q4 2014.